Pharmacokinetic Study of Gardenoside,notoginsenoside R1,ginsenoside Rg1 and Ginsenoside Rb1 in Beagle Dogs after Oral Administration of Yizhi Hydrophilic Matrix Tablets

WU Hui-chao,LU Yang,DU Shou-ying,LI Dong-xue,ZHAI Yong-song,ZHAO Jing-yi,XING Yu-shu
2014-01-01
Abstract:Objective: To discuss plasma pharmacokinetics of gardenoside, notoginsenoside R1, ginsenoside Rg1 and ginsenoside Rb1 in beagle dogs after oral administration of YizhfiHydrophilic Matrix Tablets, and to compare its bioavailability with YizhfiConventional Tablets. Methods: Based on HPLC-MS/MS analysis which was developed in our precious study, concentrations of gardenoside, Panaxnotoginsenoside R1, ginsenoside Rg1 and ginsenoside Rb1 were derived directly from the experimental points and pharmacokinetic parameters were estimated using Kinetica 4.4 software. Results: Pharmacokinetic parameters of four compounds were statistically significant increased(P0.05) including Cmax, AUC, MRT for gardenoside, R1 and Rb1, AUC and MRT for Rg1. Conclusion: The pharmacokinetic parameters provide information for the study of matrix formulation applied in Chinese compound sustained-release preparation. The formulation modification of using HPMC(hydroxyl propyl methyl cellulose) to prepare Hydrophilic Matrix Tablet is effective in enhancing the bioavailability of gardenoside and Panax notoginsenoside(PNS), thus improving its potential therapeutic ef ect and broadening its clinical application.
What problem does this paper attempt to address?